SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 64 filers reported holding SCHOLAR ROCK HLDG CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,471,745 | +16.2% | 207,288 | +23.3% | 0.00% | – |
| Q2 2023 | $1,267,104 | +636.7% | 168,051 | +435.0% | 0.00% | – |
| Q2 2022 | $172,000 | -86.8% | 31,409 | -70.9% | 0.00% | – |
| Q1 2022 | $1,304,000 | -48.7% | 107,787 | +5.3% | 0.00% | -100.0% |
| Q4 2021 | $2,542,000 | +100.6% | 102,317 | +10.7% | 0.00% | – |
| Q3 2021 | $1,267,000 | -3.1% | 92,403 | -3.0% | 0.00% | – |
| Q2 2021 | $1,307,000 | -17.2% | 95,257 | -17.1% | 0.00% | -100.0% |
| Q1 2021 | $1,578,000 | -0.1% | 114,963 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $1,580,000 | -27.4% | 115,227 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $2,175,000 | -4.2% | 122,923 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $2,270,000 | +88.7% | 124,618 | +25.4% | 0.00% | 0.0% |
| Q1 2020 | $1,203,000 | +113.3% | 99,355 | +132.5% | 0.00% | – |
| Q4 2019 | $564,000 | +10.8% | 42,741 | -24.9% | 0.00% | – |
| Q3 2019 | $509,000 | -48.0% | 56,923 | -7.7% | 0.00% | – |
| Q2 2019 | $979,000 | – | 61,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 4,598,828 | $32,651,679 | 10.00% |
| Artal Group S.A. | 9,059,507 | $64,322 | 2.76% |
| Redmile Group, LLC | 4,733,248 | $33,606,061 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 310,398 | $2,203,826 | 0.43% |
| Orbimed Advisors | 2,033,789 | $14,439,902 | 0.31% |
| Bellevue Group AG | 2,137,925 | $15,179,268 | 0.24% |
| DENALI ADVISORS LLC | 47,700 | $338,670 | 0.12% |
| Corton Capital Inc. | 27,992 | $198,743 | 0.10% |
| Deep Track Capital, LP | 353,855 | $2,512,371 | 0.10% |
| Polar Capital Holdings Plc | 1,501,926 | $10,663,675 | 0.08% |